Hyperlipidemia

PHILADELPHIA — Recaticimab, a novel anti-PCSK9 drug, conferred significant LDL reductions at 48 weeks in a cohort of patients with mixed hyperlipidemias already on statin therapy, a speaker reported.

VANCOUVER, British Columbia — Despite recent changes in nomenclature for metabolic dysfunction-associated steatotic liver disease, an expert here noted that clinical pathways largely remain the same and require reinforcing.

The fully monoclonal angiopoietin-like 3 antibody evinacumab conferred sustained, long-term reductions in LDL and other atherogenic lipoproteins among patients with refractory hyperlipidemia, researchers reported.

As allies in delivering evidence-based data, breaking news, professional resources and medical education to practicing clinicians, Healio and CMHC are proud to partner for the much-anticipated Cardiometabolic Health Congress.

Patients who underwent bariatric surgery for morbid obesity had a “substantial and long-lasting reduction” of lipid-lowering and antidiabetic medication use compared with patients who did not undergo surgery.

Adults who contract COVID-19 have a higher risk for developing incident diabetes in the 90 days after the infection compared with before the infection, according to data published in JAMA Network Open.

Researchers observed a positive dose-response association between dietary cholesterol and type 2 diabetes incidence, particularly in Western countries, according to a meta-analysis of prospective cohort studies.

PHILADELPHIA — When analyzing patients with rheumatoid arthritis based on their comorbidities, certain groups experienced differing survival outcomes when compared with the expected mortality of the general population.

Treatment effect of the PCSK9 inhibitor alirocumab (Praluent, Sanofi/Regeneron) vs. sham control on LDL in patients with STEMI referred for primary PCI.

ANAHEIM, Calif. — Women with polycystic ovary syndrome are more likely to develop type 2 diabetes and may develop hypertension, diabetes and hyperlipidemia earlier than those without PCOS, according to a speaker.